Effects of Near-Infrared Light on Well-Being and Health in Human Subjects with Mild Sleep-Related Complaints: A Double-Blind, Randomized, Placebo-Controlled Study.
Marina Cecilia GiménezMichelle LuxwoldaEila G Van StipriaanPauline P BollenRieks L HoekmanMarthe A KoopmansPraveen R AranyMichael R KramesAnne C BerendsRoelof A HutMarijke C M GordijnPublished in: Biology (2022)
Modern urban human activities are largely restricted to the indoors, deprived of direct sunlight containing visible and near-infrared (NIR) wavelengths at high irradiance levels. Therapeutic exposure to doses of red and NIR, known as photobiomodulation (PBM), has been effective for a broad range of conditions. In a double-blind, randomized, placebo-controlled study, we aimed to assess the effects of a PBM home set-up on various aspects of well-being, health, sleep, and circadian rhythms in healthy human subjects with mild sleep complaints. The effects of three NIR light (850 nm) doses (1, 4, or 6.5 J·cm -2 ) were examined against the placebo. Exposure was presented five days per week between 9:30 am and 12:30 pm for four consecutive weeks. The study was conducted in both summer and winter to include seasonal variation. The results showed PBM treatment only at 6.5 J·cm -2 to have consistent positive benefits on well-being and health, specifically improving mood, reducing drowsiness, reducing IFN-γ, and resting heart rate. This was only observed in winter. No significant effects on sleep or circadian rhythms were noted. This study provides further evidence that adequate exposure to NIR, especially during low sunlight conditions, such as in the winter, can be beneficial for human health and wellness.
Keyphrases
- heart rate
- double blind
- human health
- endothelial cells
- healthcare
- photodynamic therapy
- sleep quality
- public health
- placebo controlled
- physical activity
- heart rate variability
- risk assessment
- drug release
- induced pluripotent stem cells
- mental health
- fluorescence imaging
- open label
- health information
- phase iii
- fluorescent probe
- pluripotent stem cells
- blood pressure
- clinical trial
- climate change
- bipolar disorder
- particulate matter
- depressive symptoms
- preterm birth
- study protocol
- light emitting
- replacement therapy